Labsystems Diagnostics' Neonatal Toxoplasma gondii IgM FEIA is a fluorometric enzyme immunoassay intended for the determination of IgM-class antibodies to Toxoplasma gondii in blood samples dried on filter paper. The test is intended as a primary method for screening newborns for congenital toxoplasmosis (CT).
In a 5 year study in Brazil over 285 000 neonates were screened with Labsystems Diagnostics' Neonatal Toxoplasma gondii IgM FEIA and the prevalence was found to be 1/1867.
Fluorometric enzyme immunoassay for the determination of IgM antibodies to Toxoplasma gondii from dried blood spots. This is the first Neonatal Toxoplasma screening test in the world.
Neonatal Toxoplasma gondii IgM FEIA, 5 strip plates (12x8), 480 wells 61 99 802
- First Neonatal Toxoplasma screening test in the world
- Quantitative results
- Clinically proven performance
- High sensitive µ-capture test
#3F, Third Floor, Uppals Plaza M6, Plot No. 6, Jasola District Center, New Delhi, Delhi, 110025, India